TreeWAS – Variant ID: rs3780181

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.000	0.001	0.999
C78.0 Secondary malignant neoplasm of lung	0.000	0.001	0.999
C79 Secondary malignant neoplasm of other sites	0.000	0.005	0.995
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.000	0.005	0.995
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.000	0.011	0.989
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.000	0.020	0.980
C78.2 Secondary malignant neoplasm of pleura	0.000	0.024	0.976
C78.7 Secondary malignant neoplasm of liver	0.000	0.102	0.898
C79.7 Secondary malignant neoplasm of adrenal gland	0.000	0.189	0.811
C79.8 Secondary malignant neoplasm of other specified sites	0.000	0.207	0.793
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.000	0.220	0.779
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.000	0.221	0.779
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.000	0.246	0.754
C78.4 Secondary malignant neoplasm of small intestine	0.000	0.248	0.752
C79.2 Secondary malignant neoplasm of skin	0.000	0.274	0.726
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.000	0.284	0.716
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.000	0.286	0.714
C76 Malignant neoplasm of other and ill-defined sites	0.000	0.286	0.714
C79.9 Secondary malignant neoplasm, unspecified site	0.000	0.290	0.710
C79.6 Secondary malignant neoplasm of ovary	0.000	0.294	0.706
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.000	0.314	0.686
C77.1 Intrathoracic lymph nodes	0.000	0.317	0.683
C77.4 Inguinal and lower limb lymph nodes	0.000	0.322	0.678
C78.1 Secondary malignant neoplasm of mediastinum	0.000	0.322	0.678
C77.8 Lymph nodes of multiple regions	0.000	0.337	0.663
C77.2 Intra-abdominal lymph nodes	0.000	0.338	0.662
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.000	0.402	0.598
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.000	0.464	0.535
C76.8 Overlapping lesion of other and ill-defined sites	0.000	0.488	0.512
C76.7 Other ill-defined sites	0.000	0.488	0.512
C76.5 Lower limb	0.000	0.488	0.512
C76.4 Upper limb	0.000	0.488	0.512
C76.3 Pelvis	0.000	0.488	0.512
C76.2 Abdomen	0.000	0.488	0.512
C76.1 Thorax	0.000	0.488	0.512
C76.0 Head, face and neck	0.000	0.488	0.512
C80 Malignant neoplasm without specification of site	0.000	0.523	0.477
C77.9 Lymph node, unspecified	0.000	0.583	0.416
C77.5 Intrapelvic lymph nodes	0.000	0.585	0.415
C77.0 Lymph nodes of head, face and neck	0.000	0.679	0.321
C77.3 Axillary and upper limb lymph nodes	0.000	0.715	0.285
C80.9 Malignant neoplasm, unspecified	0.000	0.734	0.265
C80.0 Malignant neoplasm, primary site unknown, so stated	0.000	0.759	0.240
Z51.2 Other chemotherapy	0.000	0.829	0.171
Z51.5 Palliative care	0.000	0.831	0.169
Z51 Other medical care	0.000	0.841	0.159
Z51.8 Other specified medical care	0.000	0.865	0.135
Z51.9 Medical care, unspecified	0.000	0.874	0.126
Z51.4 Preparatory care for treatment, not elsewhere classified	0.000	0.889	0.111
Z51.3 Blood transfusion without reported diagnosis	0.000	0.894	0.106
Z51.6 Desensitisation to allergens	0.000	0.905	0.095
Z51.0 Radiotherapy session	0.000	0.943	0.057
Z51.1 Chemotherapy session for neoplasm	0.000	0.945	0.055
O34.2 Maternal care due to uterine scar from previous surgery	0.011	0.989	0.000
B34.9 Viral infection, unspecified	0.011	0.989	0.000
R41.0 Disorientation, unspecified	0.000	0.989	0.011
R54 Senility	0.000	0.990	0.010
A04.5 Campylobacter enteritis	0.000	0.990	0.010
E21.3 Hyperparathyroidism, unspecified	0.008	0.992	0.000
B34 Viral infection of unspecified site	0.007	0.993	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.006	0.993	0.000
I67.8 Other specified cerebrovascular diseases	0.000	0.993	0.007
O34 Maternal care for known or suspected abnormality of pelvic organs	0.006	0.994	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.006	0.994	0.000
B34.4 Papovirus infection, unspecified	0.006	0.994	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.006	0.994	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.006	0.994	0.000
O34.1 Maternal care for tumour of corpus uteri	0.006	0.994	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.006	0.994	0.000
B34.8 Other viral infections of unspecified site	0.005	0.994	0.000
B34.3 Parvovirus infection, unspecified	0.005	0.994	0.000
B34.2 Coronavirus infection, unspecified	0.005	0.994	0.000
B34.1 Enterovirus infection, unspecified	0.005	0.994	0.000
B34.0 Adenovirus infection, unspecified	0.005	0.994	0.000
R59.0 Localised enlarged lymph nodes	0.000	0.994	0.006
T50.4 Drugs affecting uric acid metabolism	0.005	0.995	0.000
N73.6 Female pelvic peritoneal adhesions	0.000	0.995	0.005
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.005	0.995	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.005	0.995	0.000
N99.3 Prolapse of vaginal vault after hysterectomy	0.000	0.995	0.005
S01.5 Open wound of lip and oral cavity	0.000	0.995	0.005
A04 Other bacterial intestinal infections	0.000	0.995	0.005
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.005	0.995	0.000
S01 Open wound of head	0.000	0.995	0.005
O34.8 Maternal care for other abnormalities of pelvic organs	0.005	0.995	0.000
O34.9 Maternal care for abnormality of pelvic organ, unspecified	0.005	0.995	0.000
O34.6 Maternal care for abnormality of vagina	0.005	0.995	0.000
O34.5 Maternal care for other abnormalities of gravid uterus	0.005	0.995	0.000
O34.4 Maternal care for other abnormalities of cervix	0.005	0.995	0.000
O34.3 Maternal care for cervical incompetence	0.005	0.995	0.000
O34.0 Maternal care for congenital malformation of uterus	0.005	0.995	0.000
T50.8 Diagnostic agents	0.005	0.995	0.000
T50.7 Analeptics and opioid receptor antagonists	0.005	0.995	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.005	0.995	0.000
T50.5 Appetite depressants	0.005	0.995	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.005	0.995	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.005	0.995	0.000
T50.1 Loop [high-ceiling] diuretics	0.005	0.995	0.000
T50.0 Mineralocorticoids and their antagonists	0.005	0.995	0.000
S01.4 Open wound of cheek and temporomandibular area	0.000	0.995	0.005
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.005	0.995	0.000
S01.8 Open wound of other parts of head	0.000	0.995	0.005
T45.5 Anticoagulants	0.004	0.995	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.004	0.995	0.000
T40.4 Other synthetic narcotics	0.004	0.995	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.004	0.995	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.004	0.996	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.996	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.004	0.996	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.004	0.996	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.004	0.996	0.000
T36 Poisoning by systemic antibiotics	0.004	0.996	0.000
O34.7 Maternal care for abnormality of vulva and perineum	0.004	0.996	0.000
S01.1 Open wound of eyelid and periocular area	0.000	0.996	0.004
S01.0 Open wound of scalp	0.000	0.996	0.004
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.004	0.996	0.000
T39.4 Antirheumatics, not elsewhere classified	0.004	0.996	0.000
T39.2 Pyrazolone derivatives	0.004	0.996	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.004	0.996	0.000
T39.0 Salicylates	0.004	0.996	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
A04.7 Enterocolitis due to Clostridium difficile	0.000	0.996	0.004
S01.2 Open wound of nose	0.000	0.996	0.004
D07.5 Prostate	0.004	0.996	0.000
H61.0 Perichondritis of external ear	0.004	0.996	0.000
T42.4 Benzodiazepines	0.004	0.996	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.004	0.996	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.004	0.996	0.000
T42.3 Barbiturates	0.004	0.996	0.000
T42.2 Succinimides and oxazolidinediones	0.004	0.996	0.000
T42.1 Iminostilbenes	0.004	0.996	0.000
T42.0 Hydantoin derivatives	0.004	0.996	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.004	0.996	0.000
T45.0 Antiallergic and antiemetic drugs	0.004	0.996	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.004	0.996	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.004	0.996	0.000
T45.8 Other primarily systemic and haematological agents	0.004	0.996	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.004	0.996	0.000
T45.6 Fibrinolysis-affecting drugs	0.004	0.996	0.000
T45.4 Iron and its compounds	0.004	0.996	0.000
T45.3 Enzymes, not elsewhere classified	0.004	0.996	0.000
T45.2 Vitamins, not elsewhere classified	0.004	0.996	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.004	0.996	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.004	0.996	0.000
A04.9 Bacterial intestinal infection, unspecified	0.000	0.996	0.004
A04.6 Enteritis due to Yersinia enterocolitica	0.000	0.996	0.004
A04.4 Other intestinal Escherichia coli infections	0.000	0.996	0.004
A04.3 Enterohaemorrhagic Escherichia coli infection	0.000	0.996	0.004
A04.2 Enteroinvasive Escherichia coli infection	0.000	0.996	0.004
A04.1 Enterotoxigenic Escherichia coli infection	0.000	0.996	0.004
A04.0 Enteropathogenic Escherichia coli infection	0.000	0.996	0.004
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.004	0.996	0.000
T40.8 Lysergide [LSD]	0.004	0.996	0.000
T40.7 Cannabis (derivatives)	0.004	0.996	0.000
T40.5 Cocaine	0.004	0.996	0.000
T40.3 Methadone	0.004	0.996	0.000
T40.1 Heroin	0.004	0.996	0.000
T40.0 Opium	0.004	0.996	0.000
T39.1 4-Aminophenol derivatives	0.004	0.996	0.000
T40.6 Other and unspecified narcotics	0.004	0.996	0.000
S01.9 Open wound of head, part unspecified	0.000	0.996	0.004
H25.8 Other senile cataract	0.000	0.996	0.004
S01.3 Open wound of ear	0.000	0.996	0.004
R41 Other symptoms and signs involving cognitive functions and awareness	0.000	0.996	0.004
T43.6 Psychostimulants with abuse potential	0.004	0.996	0.000
H60 Otitis externa	0.004	0.996	0.000
H60.1 Cellulitis of external ear	0.004	0.996	0.000
T40.2 Other opioids	0.003	0.996	0.000
A04.8 Other specified bacterial intestinal infections	0.000	0.996	0.004
T46.1 Calcium-channel blockers	0.003	0.996	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.003	0.996	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.996	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.003	0.996	0.000
T46.7 Peripheral vasodilators	0.003	0.996	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.996	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.003	0.996	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.996	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.996	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.996	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.996	0.000
T47.7 Emetics	0.003	0.996	0.000
T47.6 Antidiarrhoeal drugs	0.003	0.996	0.000
T47.5 Digestants	0.003	0.996	0.000
T47.4 Other laxatives	0.003	0.996	0.000
T47.3 Saline and osmotic laxatives	0.003	0.996	0.000
T47.2 Stimulant laxatives	0.003	0.996	0.000
T47.0 Histamine H(2)-receptor antagonists	0.003	0.996	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.003	0.997	0.000
T36.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
T36.8 Other systemic antibiotics	0.003	0.997	0.000
T36.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
T36.6 Rifamycins	0.003	0.997	0.000
T36.5 Aminoglycosides	0.003	0.997	0.000
T36.4 Tetracyclines	0.003	0.997	0.000
T36.3 Macrolides	0.003	0.997	0.000
T36.2 Chloramphenicol group	0.003	0.997	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.003	0.997	0.000
T36.0 Penicillins	0.003	0.997	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
T37.5 Antiviral drugs	0.003	0.997	0.000
T37.4 Anthelminthics	0.003	0.997	0.000
T37.3 Other antiprotozoal drugs	0.003	0.997	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
T37.1 Antimycobacterial drugs	0.003	0.997	0.000
T37.0 Sulphonamides	0.003	0.997	0.000
T38.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
T38.7 Androgens and anabolic congeners	0.003	0.997	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
T38.5 Other oestrogens and progestogens	0.003	0.997	0.000
T38.4 Oral contraceptives	0.003	0.997	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
T38.2 Antithyroid drugs	0.003	0.997	0.000
T38.1 Thyroid hormones and substitutes	0.003	0.997	0.000
T38.0 Glucocorticoids and synthetic analogues	0.003	0.997	0.000
T41.5 Therapeutic gases	0.003	0.997	0.000
T41.4 Anaesthetic, unspecified	0.003	0.997	0.000
T41.3 Local anaesthetics	0.003	0.997	0.000
T41.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
T41.1 Intravenous anaesthetics	0.003	0.997	0.000
T41.0 Inhaled anaesthetics	0.003	0.997	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
T48.5 Anti-common-cold drugs	0.003	0.997	0.000
T48.4 Expectorants	0.003	0.997	0.000
T48.3 Antitussives	0.003	0.997	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
T48.0 Oxytocic drugs	0.003	0.997	0.000
T49.9 Topical agent, unspecified	0.003	0.997	0.000
T49.8 Other topical agents	0.003	0.997	0.000
T49.7 Dental drugs, topically applied	0.003	0.997	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
T49.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
T49.3 Emollients, demulcents and protectants	0.003	0.997	0.000
T49.2 Local astringents and local detergents	0.003	0.997	0.000
T49.1 Antipruritics	0.003	0.997	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
T43.2 Other and unspecified antidepressants	0.003	0.997	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.003	0.997	0.000
H61 Other disorders of external ear	0.003	0.997	0.000
B25-B34 Other viral diseases	0.003	0.997	0.000
T43.9 Psychotropic drug, unspecified	0.003	0.997	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.003	0.997	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.003	0.997	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.997	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.003	0.997	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.003	0.997	0.000
T44.0 Anticholinesterase agents	0.003	0.997	0.000
H60.4 Cholesteatoma of external ear	0.003	0.997	0.000
R59 Enlarged lymph nodes	0.000	0.997	0.003
H25.0 Senile incipient cataract	0.000	0.997	0.003
S01.7 Multiple open wounds of head	0.000	0.997	0.003
R41.3 Other amnesia	0.000	0.997	0.003
E21.5 Disorder of parathyroid gland, unspecified	0.003	0.997	0.000
E21.4 Other specified disorders of parathyroid gland	0.003	0.997	0.000
E21.2 Other hyperparathyroidism	0.003	0.997	0.000
H60.8 Other otitis externa	0.003	0.997	0.000
H53.1 Subjective visual disturbances	0.000	0.997	0.003
T46.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.003	0.997	0.000
H60-H62 Diseases of external ear	0.003	0.997	0.000
H60.5 Acute otitis externa, non-infective	0.003	0.997	0.000
H61.1 Non-infective disorders of pinna	0.003	0.997	0.000
H54.7 Unspecified visual loss	0.000	0.997	0.003
H60.3 Other infective otitis externa	0.003	0.997	0.000
E21.0 Primary hyperparathyroidism	0.003	0.997	0.000
R41.2 Retrograde amnesia	0.000	0.997	0.003
T43.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.997	0.000
N32.0 Bladder-neck obstruction	0.003	0.997	0.000
H60.2 Malignant otitis externa	0.003	0.997	0.000
H60.0 Abscess of external ear	0.003	0.997	0.000
S30.8 Other superficial injuries of abdomen, lower back and pelvis	0.000	0.997	0.003
H61.3 Acquired stenosis of external ear canal	0.003	0.997	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.997	0.000
R59.1 Generalised enlarged lymph nodes	0.000	0.997	0.003
R59.9 Enlarged lymph nodes, unspecified	0.000	0.997	0.003
N99 Postprocedural disorders of genito-urinary system, not elsewhere classified	0.000	0.997	0.003
H25 Senile cataract	0.000	0.997	0.003
B27 Infectious mononucleosis	0.003	0.997	0.000
H61.9 Disorder of external ear, unspecified	0.003	0.997	0.000
B33 Other viral diseases, not elsewhere classified	0.002	0.997	0.000
B30 Viral conjunctivitis	0.002	0.997	0.000
B26 Mumps	0.002	0.997	0.000
K86.1 Other chronic pancreatitis	0.000	0.997	0.003
B25 Cytomegaloviral disease	0.002	0.997	0.000
R41.1 Anterograde amnesia	0.000	0.997	0.002
J32.0 Chronic maxillary sinusitis	0.003	0.997	0.000
N99.8 Other postprocedural disorders of genito-urinary system	0.000	0.997	0.002
S66.3 Injury of extensor muscle and tendon of other finger at wrist and hand level	0.000	0.997	0.003
K86.8 Other specified diseases of pancreas	0.000	0.997	0.003
H62 Disorders of external ear in diseases classified elsewhere	0.002	0.998	0.000
H60.9 Otitis externa, unspecified	0.002	0.998	0.000
H53 Visual disturbances	0.000	0.998	0.002
N99.0 Postprocedural renal failure	0.000	0.998	0.002
M25.57 Pain in joint (Ankle and foot)	0.000	0.998	0.002
S72.00 Fracture of neck of femur (closed)	0.000	0.998	0.002
H61.8 Other specified disorders of external ear	0.002	0.998	0.000
H53.2 Diplopia	0.000	0.998	0.002
H90.5 Sensorineural hearing loss, unspecified	0.002	0.998	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
G20 Parkinson's disease	0.000	0.998	0.002
F52.2 Failure of genital response	0.002	0.998	0.000
B27.9 Infectious mononucleosis, unspecified	0.002	0.998	0.000
H25.2 Senile cataract, morgagnian type	0.000	0.998	0.002
N99.9 Postprocedural disorder of genito-urinary system, unspecified	0.000	0.998	0.002
Z35.2 Supervision of pregnancy with other poor reproductive or obstetric history	0.002	0.998	0.000
Z47.8 Other specified orthopaedic follow-up care	0.002	0.998	0.000
B27.8 Other infectious mononucleosis	0.002	0.998	0.000
B27.1 Cytomegaloviral mononucleosis	0.002	0.998	0.000
B27.0 Gammaherpesviral mononucleosis	0.002	0.998	0.000
H53.0 Amblyopia ex anopsia	0.000	0.998	0.002
N73 Other female pelvic inflammatory diseases	0.000	0.998	0.002
B26.9 Mumps without complication	0.002	0.998	0.000
B26.8 Mumps with other complications	0.002	0.998	0.000
B26.3 Mumps pancreatitis	0.002	0.998	0.000
B26.2 Mumps encephalitis	0.002	0.998	0.000
B26.1 Mumps meningitis	0.002	0.998	0.000
B26.0 Mumps orchitis	0.002	0.998	0.000
B30.9 Viral conjunctivitis, unspecified	0.002	0.998	0.000
B30.8 Other viral conjunctivitis	0.002	0.998	0.000
B30.3 Acute epidemic haemorrhagic conjunctivitis (enteroviral)	0.002	0.998	0.000
B30.2 Viral pharyngoconjunctivitis	0.002	0.998	0.000
B30.1 Conjunctivitis due to adenovirus	0.002	0.998	0.000
B30.0 Keratoconjunctivitis due to adenovirus	0.002	0.998	0.000
B33.8 Other specified viral diseases	0.002	0.998	0.000
B33.4 Hantavirus (cardio-)pulmonary syndrome [HPS] [HCPS]	0.002	0.998	0.000
B33.3 Retrovirus infections, not elsewhere classified	0.002	0.998	0.000
B33.2 Viral carditis	0.002	0.998	0.000
B33.1 Ross River disease	0.002	0.998	0.000
B33.0 Epidemic myalgia	0.002	0.998	0.000
N99.1 Postprocedural urethral stricture	0.000	0.998	0.002
K86 Other diseases of pancreas	0.000	0.998	0.002
B25.8 Other cytomegaloviral diseases	0.002	0.998	0.000
B25.2 Cytomegaloviral pancreatitis	0.002	0.998	0.000
B25.1 Cytomegaloviral hepatitis	0.002	0.998	0.000
B25.0 Cytomegaloviral pneumonitis	0.002	0.998	0.000
H04.1 Other disorders of lachrymal gland	0.002	0.998	0.000
D07 Carcinoma in situ of other and unspecified genital organs	0.002	0.998	0.000
K86.0 Alcohol-induced chronic pancreatitis	0.000	0.998	0.002
H25.1 Senile nuclear cataract	0.000	0.998	0.002
B25.9 Cytomegaloviral disease, unspecified	0.002	0.998	0.000
H54 Blindness and low vision	0.000	0.998	0.002
S22.00 Fracture of thoracic vertebra (closed)	0.000	0.998	0.002
H53.6 Night blindness	0.000	0.998	0.002
H53.5 Colour vision deficiencies	0.000	0.998	0.002
H53.3 Other disorders of binocular vision	0.000	0.998	0.002
H62.8 Other disorders of external ear in diseases classified elsewhere	0.002	0.998	0.000
H62.4 Otitis externa in other diseases classified elsewhere	0.002	0.998	0.000
H62.3 Otitis externa in other infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
H62.2 Otitis externa in mycoses	0.002	0.998	0.000
H62.1 Otitis externa in viral diseases classified elsewhere	0.002	0.998	0.000
H62.0 Otitis externa in bacterial diseases classified elsewhere	0.002	0.998	0.000
L03.2 Cellulitis of face	0.002	0.998	0.000
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified	0.002	0.998	0.000
M89.97 Disorder of bone, unspecified (Ankle and foot)	0.000	0.998	0.002
H53.4 Visual field defects	0.000	0.998	0.002
H72.9 Perforation of tympanic membrane, unspecified	0.002	0.998	0.000
N99.4 Postprocedural pelvic peritoneal adhesions	0.000	0.998	0.002
N99.2 Postprocedural adhesions of vagina	0.000	0.998	0.002
Z95.1 Presence of aortocoronary bypass graft	0.000	0.998	0.002
N13.2 Hydronephrosis with renal and ureteral calculous obstruction	0.002	0.998	0.000
Z35.5 Supervision of elderly primigravida	0.002	0.998	0.000
I35.1 Aortic (valve) insufficiency	0.000	0.998	0.002
M54.22 Cervicalgia (Cervical region)	0.000	0.998	0.002
K86.2 Cyst of pancreas	0.000	0.998	0.002
N99.5 Malfunction of external stoma of urinary tract	0.000	0.998	0.002
H53.8 Other visual disturbances	0.000	0.998	0.002
M51.2 Other specified intervertebral disk displacement	0.000	0.998	0.002
Z35 Supervision of high-risk pregnancy	0.002	0.998	0.000
H61.2 Impacted cerumen	0.002	0.998	0.000
Z35.8 Supervision of other high-risk pregnancies	0.002	0.998	0.000
D07.1 Vulva	0.002	0.998	0.000
F43.2 Adjustment disorders	0.002	0.998	0.000
N73.8 Other specified female pelvic inflammatory diseases	0.000	0.998	0.002
N73.5 Female pelvic peritonitis, unspecified	0.000	0.998	0.002
N73.4 Female chronic pelvic peritonitis	0.000	0.998	0.002
N73.3 Female acute pelvic peritonitis	0.000	0.998	0.002
N73.2 Unspecified parametritis and pelvic cellulitis	0.000	0.998	0.002
N73.1 Chronic parametritis and pelvic cellulitis	0.000	0.998	0.002
N73.0 Acute parametritis and pelvic cellulitis	0.000	0.998	0.002
Z97.8 Presence of other specified devices	0.002	0.998	0.000
D07.6 Other and unspecified male genital organs	0.002	0.998	0.000
D07.4 Penis	0.002	0.998	0.000
D07.3 Other and unspecified female genital organs	0.002	0.998	0.000
D07.2 Vagina	0.002	0.998	0.000
D07.0 Endometrium	0.002	0.998	0.000
N94.1 Dyspareunia	0.002	0.998	0.000
Z22.5 Carrier of viral hepatitis	0.000	0.998	0.002
T93.3 Sequelae of dislocation, sprain and strain of lower limb	0.002	0.998	0.000
T93.2 Sequelae of other fractures of lower limb	0.002	0.998	0.000
H54.6 Unqualified visual loss, one eye	0.000	0.998	0.002
H54.5 Low vision, one eye	0.000	0.998	0.002
H54.3 Unqualified visual loss, both eyes	0.000	0.998	0.002
H54.2 Low vision, both eyes	0.000	0.998	0.002
H54.1 Blindness, one eye, low vision, other eye	0.000	0.998	0.002
R41.8 Other and unspecified symptoms and signs involving cognitive functions and awareness	0.000	0.998	0.002
N81.2 Incomplete uterovaginal prolapse	0.002	0.998	0.000
I67 Other cerebrovascular diseases	0.000	0.998	0.002
H53-H54 Visual disturbances and blindness	0.000	0.998	0.002
R52.1 Chronic intractable pain	0.000	0.998	0.002
J02.9 Acute pharyngitis, unspecified	0.000	0.998	0.002
H54.4 Blindness, one eye	0.000	0.998	0.002
K86.3 Pseudocyst of pancreas	0.000	0.998	0.002
Z35.0 Supervision of pregnancy with history of infertility	0.002	0.998	0.000
W06.0 Home	0.002	0.998	0.000
I35.2 Aortic (valve) stenosis with insufficiency	0.000	0.998	0.002
N13.6 Pyonephrosis	0.002	0.998	0.000
N30.8 Other cystitis	0.002	0.998	0.000
Z35.9 Supervision of high-risk pregnancy, unspecified	0.002	0.998	0.000
H72 Perforation of tympanic membrane	0.002	0.998	0.000
F03 Unspecified dementia	0.000	0.998	0.002
N73.9 Female pelvic inflammatory disease, unspecified	0.000	0.998	0.002
Z35.7 Supervision of high-risk pregnancy due to social problems	0.002	0.998	0.000
Z35.6 Supervision of very young primigravida	0.002	0.998	0.000
Z35.4 Supervision of pregnancy with grand multiparity	0.002	0.998	0.000
Z35.3 Supervision of pregnancy with history of insufficient antenatal care	0.002	0.998	0.000
Z22.3 Carrier of other specified bacterial diseases	0.000	0.998	0.002
Z35.1 Supervision of pregnancy with history of abortive outcome	0.002	0.998	0.000
E27.8 Other specified disorders of adrenal gland	0.002	0.998	0.000
S20.8 Superficial injuries of other and unspecified parts of thorax	0.000	0.998	0.002
N13.7 Vesicoureteral-reflux-associated uropathy	0.002	0.998	0.000
T83.0 Mechanical complication of urinary (indwelling) catheter	0.002	0.998	0.000
H25.9 Senile cataract, unspecified	0.000	0.998	0.002
H54.9 Unspecified visual impairment (binocular)	0.000	0.998	0.001
N92.3 Ovulation bleeding	0.000	0.998	0.002
Z97.0 Presence of artificial eye	0.002	0.998	0.000
H54.0 Blindness, both eyes	0.000	0.998	0.001
I67.7 Cerebral arteritis, not elsewhere classified	0.000	0.998	0.001
I67.6 Nonpyogenic thrombosis of intracranial venous system	0.000	0.998	0.001
I67.5 Moyamoya disease	0.000	0.998	0.001
I67.4 Hypertensive encephalopathy	0.000	0.998	0.001
I67.3 Progressive vascular leukoencephalopathy	0.000	0.998	0.001
T93 Sequelae of injuries of lower limb	0.002	0.998	0.000
F43.9 Reaction to severe stress, unspecified	0.001	0.998	0.000
H70.9 Mastoiditis, unspecified	0.001	0.998	0.000
H72.0 Central perforation of tympanic membrane	0.001	0.998	0.000
S72.0 Fracture of neck of femur	0.000	0.998	0.001
N13 Obstructive and reflux uropathy	0.002	0.998	0.000
H72.2 Other marginal perforations of tympanic membrane	0.001	0.998	0.000
K72.9 Hepatic failure, unspecified	0.001	0.998	0.000
K86.9 Disease of pancreas, unspecified	0.000	0.998	0.001
S02.40 Fracture of malar and maxillary bones (closed)	0.000	0.998	0.001
M50.3 Other cervical disk degeneration	0.000	0.998	0.001
M50.2 Other cervical disk displacement	0.000	0.998	0.001
N94.8 Other specified conditions associated with female genital organs and menstrual cycle	0.001	0.998	0.000
H72.1 Attic perforation of tympanic membrane	0.001	0.999	0.000
Z97.4 Presence of external hearing-aid	0.001	0.999	0.000
H70 Mastoiditis and related conditions	0.001	0.999	0.000
S30 Superficial injury of abdomen, lower back and pelvis	0.000	0.999	0.001
E29.1 Testicular hypofunction	0.001	0.999	0.000
F43.0 Acute stress reaction	0.001	0.999	0.000
I67.0 Dissection of cerebral arteries, nonruptured	0.000	0.999	0.001
F43 Reaction to severe stress, and adjustment disorders	0.001	0.999	0.000
Z22 Carrier of infectious disease	0.000	0.999	0.001
E20-E35 Disorders of other endocrine glands	0.001	0.999	0.000
H65-H75 Diseases of middle ear and mastoid	0.001	0.999	0.000
S62.30 Fracture of other metacarpal bone (closed)	0.000	0.999	0.001
D05.9 Carcinoma in situ of breast, unspecified	0.000	0.999	0.001
E29 Testicular dysfunction	0.001	0.999	0.000
M54.29 Cervicalgia-Site unspe	0.000	0.999	0.001
K91.4 Colostomy and enterostomy malfunction	0.000	0.999	0.001
S22.0 Fracture of thoracic vertebra	0.000	0.999	0.001
F43.1 Posttraumatic stress disorder	0.001	0.999	0.000
S83.5 Sprain and strain involving (anterior)(posterior) cruciate ligament of knee	0.001	0.999	0.000
Z50.2 Alcohol rehabilitation	0.000	0.999	0.001
M50 Cervical disk disorders	0.000	0.999	0.001
H74.8 Other specified disorders of middle ear and mastoid	0.001	0.999	0.000
S30.9 Superficial injury of abdomen, lower back and pelvis, part unspecified	0.000	0.999	0.001
S30.0 Contusion of lower back and pelvis	0.000	0.999	0.001
F52 Sexual dysfunction, not caused by organic disorder or disease	0.001	0.999	0.000
H73 Other disorders of tympanic membrane	0.001	0.999	0.000
H73.9 Disorder of tympanic membrane, unspecified	0.001	0.999	0.000
M50.0 Cervical disk disorder with myelopathy	0.000	0.999	0.001
Z97.3 Presence of spectacles and contact lenses	0.001	0.999	0.000
S72.01 Fracture of neck of femur (open)	0.000	0.999	0.001
D12.3 Transverse colon	0.001	0.999	0.000
T93.6 Sequelae of crushing injury and traumatic amputation of lower limb	0.001	0.999	0.000
T93.5 Sequelae of injury of muscle and tendon of lower limb	0.001	0.999	0.000
T93.4 Sequelae of injury of nerve of lower limb	0.001	0.999	0.000
T93.0 Sequelae of open wound of lower limb	0.001	0.999	0.000
Z47.0 Follow-up care involving removal of fracture plate and other internal fixation device	0.001	0.999	0.000
H53.9 Visual disturbance, unspecified	0.000	0.999	0.001
T93.8 Sequelae of other specified injuries of lower limb	0.001	0.999	0.000
E27 Other disorders of adrenal gland	0.001	0.999	0.000
H74 Other disorders of middle ear and mastoid	0.001	0.999	0.000
Z47 Other orthopaedic follow-up care	0.001	0.999	0.000
Z97 Presence of other devices	0.001	0.999	0.000
H47.1 Papilloedema, unspecified	0.001	0.999	0.000
H70.8 Other mastoiditis and related conditions	0.001	0.999	0.000
H70.2 Petrositis	0.001	0.999	0.000
H70.1 Chronic mastoiditis	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations